Get Updates on MIGS
Menu
Get Updates on MIGS
DON'T WAIT
FOR TOO LATE
Glaucoma is a silent threat that can lurk
below the surface. Minimally invasive
glaucoma surgery (MIGS), performed as
a solo procedure or with cataract
surgery, may be the best option for
your glaucoma patients.
DON'T WAIT
FOR TOO LATE
Glaucoma is a silent threat that can lurk below the surface. Minimally invasive glaucoma surgery (MIGS), performed as a solo procedure or with cataract surgery, may be the best option for your glaucoma patients.
WHAT YOU KNOW
ABOUT IOP IS TRUE
IOP Reduction Is the Only Way to Manage Glaucoma
Early Intervention Is Essential to Slowing Progression of the Disease
-
Controlling your patients’ IOP is directly
correlated to preserving their vision1 - Every mmHg of IOP reduction is important to slowing the progression of glaucoma1
- Maintaining IOP below 18mmHg has, on average prevented worsening of visual field1
WHAT YOU KNOW
ABOUT IOP IS TRUE
IOP Reduction Is the Only Way to Manage Glaucoma
Early Intervention Is Essential to Slowing Progression of the Disease
- Controlling your patients’ IOP is directly correlated to preserving their vision1
- Every mmHg of IOP reduction is important to slowing the progression of glaucoma1
- Maintaining IOP below 18mmHg has, on average prevented worsening of visual field1
THE TREATMENT BURDEN YOU SEE DAILY IS REAL
Drop Therapy Can Create Challenges for Glaucoma Patients
- Many patients struggle with complex dosing schedules and eye drop compliance2,3
- While drop therapy can effectively lower IOP, adherence declines over time4
- Long-term use of drops can lead to ocular surface issues5-7
THE TREATMENT BURDEN YOU SEE DAILY IS REAL
Drop Therapy Can Create Challenges for Glaucoma Patients
- Many patients struggle with complex dosing schedules and eye drop compliance2,3
- While drop therapy can effectively lower IOP, adherence declines over time4
- Long-term use of drops can lead to ocular surface issues5-7
THERE'S A SOLUTION IN SIGHT
MIGS Allows You to Proactively Treat Glaucoma
When considered early, the benefits of MIGS spans the spectrum.
CONSIDER MIGS EARLY
- Sustains IOP reduction with a strong safety profile
- Reduces medication burden and ocular surface issues
- Reduces reliance on patient compliance and alleviates ongoing cost concerns
THERE'S A SOLUTION IN SIGHT
CONSIDER MIGS EARLY
When considered early, the benefits of MIGS spans the spectrum.
- Sustains IOP reduction with a strong safety profile
- Reduces medication burden and ocular surface issues
- Improves patient compliance and alleviates cost concerns
DON'T WAIT FOR
TOO LATE
Fill out the form to find out what MIGS can do for your patients.
References:
1. The Advanced Glaucoma Intervention Study (AGIS): 7. The Relationship Between Control of Intraocular Pressure and Visual Field Deterioration. American Journal of Ophthalmology, vol. 30, no. 4, Oct. 2020, pp. 429–437.
2. Robin, Alan, and Davinder S Grover. Compliance and Adherence in Glaucoma Management.” Indian Journal of Ophthalmology, vol. 59, no. 7, Jan. 2011, pp. 93–96., doi:10.4103/0301-4738.73693.
3. MacKean, J M, and A R Elkington. Compliance with Treatment of Patients with Chronic Open-Angle Glaucoma. British Journal of Ophthalmology, vol. 67, 1983, pp. 46–49.
4. Kim, Chan Yun, et al. Treatment Patterns and Medication Adherence of Patients with Glaucoma in South Korea.” British Journal of Ophthalmology, vol. 101, no. 6, 2017, pp. 801–807., doi:10.1136/bjophthalmol-2016-308505.
5. Gazzard, Gus, et al. Selective Laser Trabeculoplasty versus Eye Drops for First-Line Treatment of Ocular Hypertension and Glaucoma (LiGHT): a Multicentre Randomised Controlled Trial. The Lancet, vol. 393, no. 10180, 2019, pp. 1505–1516., doi:10.1016/s0140-6736(18)32213-x.
6. Inoue, Kenji. “Managing Adverse Effects of Glaucoma Medications.” Clinical Ophthalmology, 2014, p. 3., doi:10.2147/opth.s44708.
7. “2019 Glaucoma Surgical Device Market Report .” Market Scope, Aug. 2019, p. 127.
